MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Integra Lifesciences Holdings Corp Company Profile (NASDAQ:IART)

Consensus Ratings for Integra Lifesciences Holdings Corp (NASDAQ:IART) (?)
Ratings Breakdown: 3 Hold Rating(s), 7 Buy Rating(s)
Consensus Rating:Buy (Score: 2.70)
Consensus Price Target: $70.50 (17.03% upside)

Current Analysts' Coverage Summary for Integra Lifesciences Holdings Corp (NASDAQ:IART)
Show:
DateFirmActionRatingPrice TargetActions
8/26/2015Lake Street CapitalLower Price TargetHold$65.00 -> $55.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/4/2015Piper JaffrayReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/31/2015JPMorgan Chase & Co.UpgradeNeutral -> Overweight$80.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/29/2015Raymond JamesUpgradeMarket Perform -> OutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/6/2015Jefferies GroupReiterated RatingBuy$67.00 -> $78.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/1/2015OppenheimerSet Price TargetBuy$76.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/29/2015BarclaysBoost Price TargetEqual Weight$63.00 -> $70.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/4/2015RBC CapitalBoost Price TargetSector Perform$62.00 -> $66.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/1/2015Wells Fargo & Co.UpgradeMarket Perform -> OutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/25/2015ArgusBoost Price TargetBuy$61.00 -> $72.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/8/2014Bank of AmericaUpgradeUnderperform -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/11/2013Morgan StanleyUpgradeUnderweight -> Equal Weight$40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 9/2/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha